0

Journal Articles

in Endocrinology
 1-20 of 592 Articles
Viewpoint |  May 13, 2013 ONLINE FIRST
Adulterated Sexual Enhancement Supplements:  More Than Mojo
Pieter A. Cohen, MD; Bastiaan J. Venhuis, PhD
JAMA Intern Med. 2013;():1-3. doi:10.1001/jamainternmed.2013.854.
Correction |  May 13, 2013
Error in Table in: Communication and Medication Refill Adherence: The Diabetes Study of Northern California
JAMA Intern Med. 2013;173(9):731. doi:10.1001/jamainternmed.2013.6768.
Editorial |  April 22, 2013 ONLINE FIRST
Trust in the Medical Literature—and Viewpoints in JAMA Internal Medicine
Robert Steinbrook, MD; Rita F. Redberg, MD, MSc
JAMA Intern Med. 2013;():1-2. doi:10.1001/jamainternmed.2013.6281.
Viewpoint |  April 22, 2013 ONLINE FIRST
Nullius In Verba:  Don't Take Anyone's Word for It
Richard S. Lehman, MA, BM,  BCh, MRCGP
JAMA Intern Med. 2013;():1-2. doi:10.1001/jamainternmed.2013.823.
Original Investigation |  April 08, 2013
Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus:  A Population-Based Matched Case-Control Study
Sonal Singh, MD, MPH; Hsien-Yen Chang, PhD; Thomas M. Richards, MS; et al.
JAMA Intern Med. 2013;173(7):534-539. doi:10.1001/jamainternmed.2013.2720.
INCLUDES: , Supplemental Content
Invited Commentary |  April 08, 2013
Glucagonlike Peptide 1–Based Drugs and Pancreatitis:  Clarity at Last, but What About Pancreatic Cancer?
Comment on “Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus”
Belinda Gier, PhD; Peter C. Butler, MD
JAMA Intern Med. 2013;173(7):539-541. doi:10.1001/jamainternmed.2013.3374.
Research Letters |  April 08, 2013
A National Survey of the Treatment of Hyperlipidemia in Primary Prevention
Michael E. Johansen, MD; Katherine J. Gold, MD, MSW, MS; Ananda Sen, PhD; et al.
JAMA Intern Med. 2013;173(7):586-588. doi:10.1001/jamainternmed.2013.2797.
INCLUDES: , Supplemental Content
Research Letters |  April 08, 2013
Benefits of Participation in Diabetes Group Visits After Trial Completion
George L. Jackson, PhD, MHA; David Edelman, MD, MHS; Maren K. Olsen, PhD; et al.
JAMA Intern Med. 2013;173(7):590-592. doi:10.1001/jamainternmed.2013.2803.
INCLUDES: , Supplemental Content
In This Issue of JAMA Internal Medicine |  March 11, 2013
In This Issue of JAMA Internal Medicine
JAMA Intern Med. 2013;173(5):333. doi:10.1001/jamainternmed.2013.2704.
Research Letters |  March 11, 2013
The Status of Baby Boomers' Health in the United States:  The Healthiest Generation?
Dana E. King, MD, MS; Eric Matheson, MD, MS; Svetlana Chirina, MPH; et al.
JAMA Intern Med. 2013;173(5):385-386. doi:10.1001/jamainternmed.2013.2006.
INCLUDES: , Supplemental Content
Original Investigation |  March 11, 2013
Participatory Surveillance of Hypoglycemia and Harms in an Online Social Network
Elissa R. Weitzman, ScD, MSc; Skyler Kelemen, BA; Maryanne Quinn, MD, MPH; et al.
JAMA Intern Med. 2013;173(5):345-351. doi:10.1001/jamainternmed.2013.2512.
Invited Commentary |  March 11, 2013
From “Pull” to “Push”: A Transformation in Medicine:  Comment on “Participatory Surveillance of Hypoglycemia and Harms in an Online Social Network”
Aaron Barak Neinstein, MD
JAMA Intern Med. 2013;173(5):352-353. doi:10.1001/jamainternmed.2013.3442.
Original Investigation |  February 11, 2013
Communication and Medication Refill Adherence:  The Diabetes Study of Northern California
Neda Ratanawongsa, MD, MPH; Andrew J. Karter, PhD; Melissa M. Parker, MS; et al.
JAMA Intern Med. 2013;173(3):210-218. doi:10.1001/jamainternmed.2013.1216.
Original Investigation |  January 28, 2013
Translating the Diabetes Prevention Program Lifestyle Intervention for Weight Loss Into Primary Care:  A Randomized Trial
Jun Ma, MD, PhD; Veronica Yank, MD; Lan Xiao, PhD; et al.
JAMA Intern Med. 2013;173(2):113-121. doi:10.1001/2013.jamainternmed.987.
INCLUDES: , Supplemental Content
In This Issue of JAMA Internal Medicine |  January 14, 2013
In This Issue of JAMA Internal Medicine
JAMA Intern Med. 2013;173(1):5. doi:10.1001/jamainternmed.2013.2680.
Original Investigation |  November 26, 2012
Effect of Legumes as Part of a Low Glycemic Index Diet on Glycemic Control and Cardiovascular Risk Factors in Type 2 Diabetes Mellitus:  A Randomized Controlled Trial
David J. A. Jenkins, MD, PhD; Cyril W. C. Kendall, PhD; Livia S. A. Augustin, PhD; et al.
Arch Intern Med. 2012;172(21):1653-1660. doi:10.1001/2013.jamainternmed.70.
INCLUDES: , Supplemental Content
Invited Commentary |  November 26, 2012
Diabetes Mellitus Nutrition Therapy: Beyond the Glycemic Index:  Comment on “Effect of Legumes as Part of a Low Glycemic Index Diet on Glycemic Control and Cardiovascular Risk Factors in Type 2 Diabetes Mellitus”
Marion J. Franz, MS, RD, CDE
Arch Intern Med. 2012;172(21):1660-1661. doi:10.1001/2013.jamainternmed.871.
Invited Commentary |  November 26, 2012
The Promise of Primary Care–Based Screening for Diabetic Retinopathy:  The Devil Will Be in the Details
Comment on “Telemedicine and Retinal Imaging for Improving Diabetic Retinopathy Evaluation”
Lauren Patty Daskivich, MD, MSHS; Carol M. Mangione, MD, MSPH
Arch Intern Med. 2012;172(21):1678-1680. doi:10.1001/2013.jamainternmed.406.
Research Letters |  November 26, 2012
Telemedicine and Retinal Imaging for Improving Diabetic Retinopathy Evaluation
Seema Garg, MD, PhD; Pooja D. Jani, MD; Abhijit V. Kshirsagar, MD, MPH; et al.
Arch Intern Med. 2012;172(21):1677-1680. doi:10.1001/archinternmed.2012.4372.
Invited Commentary |  November 12, 2012
Implementing High-Value, Cost-Conscious Diabetes Mellitus Care Through the Use of Low-Cost Medications and Less-Intensive Glycemic Control Target:  Comment on "Variation in Use of High-Cost Diabetes Mellitus Medications in the VA Healthcare System"
Timothy J. Wilt, MD, MPH; Amir Qaseem, MD, PhD, MHA
Arch Intern Med. 2012;172(20):1610-1611. doi:10.1001/2013.jamainternmed.203.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Surgery
Original Article  |  May 15, 2013
Factors That Influence Parathyroid Hormone Half-life:  Determining if New Intraoperative Criteria Are Needed
Andrew J. Leiker, BS; Tina W. F. Yen, MD, MS; Dan C. Eastwood, MS; et al.
JAMA Surgery
Invited Critique  |  May 15, 2013
Intraoperative Parathyroid Hormone Criteria: The Quest for Perfection:  Comment on “Factors That Influence Parathyroid Hormone Half-life”
Kelly L. McCoy, MD; Sally E. Carty, MD
JAMA Ophthalmology
Small Case Series  |  May 2, 2013
Intravitreal Fasudil Combined With Bevacizumab for Persistent Diabetic Macular Edema: A Novel Treatment
Hamid Ahmadieh, MD; Ramin Nourinia, MD; Ali Hafezi-Moghadam, MD, PhD
JAMA
News From the Centers for Disease Control and Prevention  |  May 01, 2013
Few Adults With Prediabetes Know About Their Condition
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems